This chapter reviews the empirical literature on the determination of firms' and industries'
innovative activity and performance, highlighting the questions addressed, the approaches …

Comparative analysis of the R&D efficiency of 14 leading pharmaceutical companies for the
years 1999–2018 shows that there is a close positive correlation between R&D spending …

Clinical development success rates for investigational drugs | Nature Biotechnology Skip to
main content Thank you for visiting nature.com. You are using a browser version with …

Purpose–This study aims to develop an original framework of green organizational identity
to explore the positive effects of environmental organizational culture and environmental …

To answer the question of when are assets complementary, we investigate specific resource
combinations along the value chain, focusing on two mechanisms that are central to …

This paper investigates the effect of (potential) market size on entry of new drugs and
pharmaceutical innovation. Focusing on exogenous changes driven by US demographic …

Do large firms produce more valuable inventions, and if so, why? After confirming that large
firms indeed produce more valuable inventions, we consider two possible sources: a …

The pharmaceutical industry accounts for a substantial chunk of the US economy's research
and development investments, which have resulted in significant medical breakthroughs. At …

This article provides an overview of the main traits of the historical development of the
pharmaceutical industry, using the lenses of the evolutionary approach to economic and …

We examine the performance of 160 pharmaceutical acquisitions from 1994 to 2001 and
find evidence that on average acquirers realize significant positive returns. These returns …